These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12219014)

  • 21. Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database.
    Hamilton RJ; Aronson WJ; Presti JC; Terris MK; Kane CJ; Amling CL; Freedland SJ
    Cancer; 2007 Nov; 110(10):2202-9. PubMed ID: 17876838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radical retropubic prostatectomy in men younger than 45 years diagnosed during early prostate cancer detection program.
    Varkarakis J; Pinggera GM; Sebe P; Berger A; Bartsch G; Horninger W
    Urology; 2004 Feb; 63(2):337-41. PubMed ID: 14972485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center.
    Freedland SJ; Jalkut M; Dorey F; Sutter ME; Aronson WJ
    Urology; 2000 Jul; 56(1):87-91. PubMed ID: 10869631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group.
    Freedland SJ; Aronson WJ; Kane CJ; Presti JC; Amling CL; Elashoff D; Terris MK
    J Clin Oncol; 2004 Feb; 22(3):446-53. PubMed ID: 14691122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003.
    Khan MA; Han M; Partin AW; Epstein JI; Walsh PC
    Urology; 2003 Jul; 62(1):86-91; discussion 91-2. PubMed ID: 12837428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
    BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease.
    Eastham JA; Kelly WK; Grossfeld GD; Small EJ;
    Urology; 2003 Dec; 62 Suppl 1():55-62. PubMed ID: 14747042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy.
    Moses KA; Chen LY; Sjoberg DD; Bernstein M; Touijer KA
    BMC Urol; 2014 Dec; 14():98. PubMed ID: 25495177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity.
    Underwood W; Wei J; Rubin MA; Montie JE; Resh J; Sanda MG
    Urol Oncol; 2004; 22(1):20-4. PubMed ID: 14969799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in radical prostatectomy and radiation therapy rates for African Americans and whites.
    Shaw M; Elterman L; Rubenstein M; McKiel CF; Guinan P
    J Natl Med Assoc; 2000 Jun; 92(6):281-4. PubMed ID: 10918763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between race and oncologic outcome following radical prostatectomy for clinically organ-confined prostate cancer: a long-term follow-up study.
    Amini E; Palmer TC; Cai J; Lieskovsky G; Daneshmand S; Djaladat H
    World J Urol; 2018 Aug; 36(8):1233-1239. PubMed ID: 29536157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database.
    Smith CV; Bauer JJ; Connelly RR; Seay T; Kane C; Foley J; Thrasher JB; Kusuda L; Moul JW
    J Urol; 2000 Dec; 164(6):1964-7. PubMed ID: 11061892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A population-based analysis of contemporary patterns of care in younger men (<60 years old) with localized prostate cancer.
    Wong AT; Safdieh JJ; Rineer J; Weiner J; Schwartz D; Schreiber D
    Int Urol Nephrol; 2015 Oct; 47(10):1629-34. PubMed ID: 26329748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE.
    Latini DM; Elkin EP; Cooperberg MR; Sadetsky N; Duchane J; Carroll PR
    Cancer; 2006 Feb; 106(4):789-95. PubMed ID: 16400651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. UK radical prostatectomy outcomes and surgeon case volume: based on an analysis of the British Association of Urological Surgeons Complex Operations Database.
    Vesey SG; McCabe JE; Hounsome L; Fowler S
    BJU Int; 2012 Feb; 109(3):346-54. PubMed ID: 21771246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men.
    Sundi D; Kryvenko ON; Carter HB; Ross AE; Epstein JI; Schaeffer EM
    J Urol; 2014 Jan; 191(1):60-7. PubMed ID: 23770146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Prostate Cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy with watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):184-90. PubMed ID: 23271771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Low Socioeconomic Status With Adverse Prostate Cancer Pathology Among African American Men Who Underwent Radical Prostatectomy.
    Weprin SA; Parker DC; Jones JD; Kaplan JR; Giusto LL; Mydlo JH; Yu SS; Lee DI; Eun DD; Reese AC
    Clin Genitourin Cancer; 2019 Oct; 17(5):e1054-e1059. PubMed ID: 31303559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.